-
THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION PUBLISHES THE RIO-NORTH AMERICA STUDY
-
SANOFI PASTEUR DELIVERS MORE H5N1 VACCINE FOR U.S. GOVERNMENT PANDEMIC INITIATIVES
-
Svenska Cardiologföreningen och sanofi-aventis stödjer forskning rörande prevention av hjärtkärlsjukdomar med utgångspunkt från kända kardiovaskulära och metabola riskfaktorer.
-
MY CHILD MATTERS: LAUNCH OF A MOBILISATION CAMPAIGN AGAINST CHILDHOOD CANCER IN EMERGING COUNTRIES
-
Dynamic growth in 2005 full-year consolidated net sales: up 9.3% on a comparable basis1
-
PLAVIX® APPROVED IN JAPAN
-
Pfizer to purchase sanofi-aventis rights to EXUBERAâ in application of change of control clauses
-
SANOFI PASTEUR TO LICENSE MICRO-DELIVERY TECHNOLOGY
-
SANOFI PASTEUR ANNOUNCES PRELIMINARY TRIAL RESULTS FOR A FIRST H5N1 PRE-PANDEMIC INFLUENZA VACCINE CANDIDATE WITH AN ADJUVANT
-
SANOFI PASTEUR SIGNS CONTRACT WITH FRENCH GOVERNMENT TO PRODUCE PANDEMIC INFLUENZA VACCINE
-
EXUBERA® INHALED INSULIN IMPROVES BLOOD SUGAR LEVELS IN ADULTS WITH TYPE 2 DIABETES BETTER THAN DIABETES PILLS ALONE 1
-
EXUBERA® RECEIVES POSITIVE OPINION FROM CHMP FOR THE TREATMENT OF TYPE 1 + TYPE 2 DIABETES
Visa mer
Loading...